Ipamorelin increases growth hormone release in human volunteers.
IpamorelinVerdict: Supported. Last reviewed Jul 1, 2026. Risk signal: High.
Peptide evidence profile
Ipamorelin
Ipamorelin is commonly discussed around growth hormone signaling, body composition, and recovery. Each claim needs a narrow evidence check.
- Category
- growth hormone secretagogue
- Profile status
- Reviewed claim available
- Last evidence check
- Jul 1, 2026
- Reviewed checks
- 2
Claims people make
Peptide Fact Checks reviews narrow claims one at a time. A claim only becomes public when it has a grade, verdict, source list, and last-reviewed date.
- recovery
- body composition
Ipamorelin is claimed to help with injury recovery in humans.
IpamorelinVerdict: Limited Evidence. Last reviewed Jul 1, 2026. Risk signal: Medium.
Regulatory context
Body-composition and hormone-related claims can trigger medical, compounding, or prescription-drug concerns.
What to watch
Do not treat hormone-signaling claims as self-use guidance. Peptide Fact Checks keeps dosing and protocol language off public pages.